MedPath

Optimal Aftercare for Stroke Survivors (OASiS): A randomised controlled trial of the effectiveness of an e-health innovation for stroke survivors and support persons

Not Applicable
Conditions
Stroke
Stroke - Haemorrhagic
Stroke - Ischaemic
Public Health - Health promotion/education
Registration Number
ACTRN12616001607460
Lead Sponsor
niverstiy of Newcastle
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Stopped early
Sex
All
Target Recruitment
128
Inclusion Criteria

Survivors will be:
Patients admitted for stroke who are conscious and not requiring a high level of medical care are eligible to participate. They will be:
* aged 18 years or older,
* less than or equal to 3 months post first ischemic or haemorrhagic stroke or Transient Ischemic Attack,
* have access to the internet,
* have a mobile phone,
* being discharged home or to private rehabilitation services, and
* able to provide informed consent.

Support person will be:
* nominated by the stroke survivors as their primary source of practical and emotional support,
* aged 18 years or older,
* have access to the internet and
* have a mobile phone,
* able to give informed consent.

Exclusion Criteria

Ineligible survivors will have:
* severe neurological impairment not associated with stroke;
* severe language or cognitive impairment; or
* insufficient English to complete measures.
* unable to access the internet/no phone.

Ineligible support persons:
* insufficient English to complete the study measures,
* unable to provide independent informed consent,
* unable to access the internet/no phone.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Depression (PQ-9) (Survivor)<br>[Baseline, 3 and 6 months post-recruitment];Quality of life (SF-12) (Survivor and Support Person)[Baseline, 3 and 6 months post-recruitment];Depression (PQ-9) (Support Person)[Baseline, 3 and 6 months post-recruitment]
Secondary Outcome Measures
NameTimeMethod
Anxiety (GAD 7) (Survivor and SP)[Baseline, 3 and 6 months post-recruitment];Self efficacy (SSEQ4) (Survivor) [6 months post-recruitment];Longer-Term Unmet Needs After Stroke (LUNS) (Survivor) [Baseline, 3 and 6 months post-recruitment];Enableme acceptability (survivor and SP) will be assessed using likert type survey questions designed specifically for this study.<br>[3 and 6 months post-recruitment]
© Copyright 2025. All Rights Reserved by MedPath